Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Collaboration › Details

Servier–Cellectis: T-cell immunotherapy, 201511– acquisition excl rights to UCART19 by Servier

	Period	2015-11-01
	Successor	Servier–Cellectis: T-cell immunotherapy, 202002– collab amendment + expansion ww excl license to develop + commercialise UCARTs tageting CD19
	Partner, 1st	Servier (Group)
	Partner, 2nd	Cellectis S.A. (Euronext Growth: ALCLS, Nasdaq: CLLS)
	Group	Cellectis (Group)
	Product	UCART19 (Cellectis / Servier / Pfizer / Allogene)
	Product 2	Chimeric Antigen Receptor T-Cell therapy (CAR-T therapy)

Record changed: 2022-11-19

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Servier (Group)

[1] Owkin. (10/17/23). "Press Release: Servier Partners with Owkin with the Aim of Discovering and Developing AI-driven Precision Therapeutics"....
[2] Aqemia SAS. (1/9/23). "Press Release: Servier and Aqemia Extend Collaboration on Undruggable Target in Immuno-Oncology". Paris....
[3] Aqemia SAS. (12/16/21). "Press Release: Aqemia and Servier Announce AI and Quantum Physics-drive Drug Discovery Collaboration in Immuno-oncology". Paris....
[4] Servier. (6/16/21). "Press Release: Servier and PRISM BioLab Enter Drug Discovery Collaboration for a Novel Target". Paris & Tokyo....
[5] MiNA Therapeutics Ltd.. (1/21/21). "Press Release: Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases". Paris & London....
[6] Cytokinetics, Inc.. (12/23/20). "Press Release: Cytokinetics Regains European Rights to Omecamtiv Mecarbil". South San Francisco, CA....
[7] Servier. (12/21/20). "Press Release: Servier to Acquire Agios Pharmaceuticals’ Oncology Business". Paris & Boston, MA....
[8] Cytokinetics, Inc.. (11/23/20). "Press Release: Cytokinetics Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 from Amgen". South San Francisco, CA....
[9] Galapagos N.V.. (10/15/20). "Press Release: Galapagos and Servier Report Topline Results for ROCCELLA Phase 2 Clinical Trial with GLPG1972/S201086 in Knee Osteoarthritis Patients". Mechelen & Paris....
[10] Servier. (10/6/20). "Press Release: The Servier Group Accelerates Its Digital Transformation and Has Named Virginie Dominguez as Chief Digital Officer". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)